August 5, 2026 Central Garden & Pet Announces Q3 Fiscal 2026 Financial Results Reports fiscal 2026 Q3 net sales decline of 8%, with organic sales growth of 2% Delivers fiscal 2026 Q3 GAAP diluted EPS of $1.45 versus $1.52 in the prior year, and…
August 5, 2026
Central Garden & Pet Announces Q3
Fiscal 2026 Financial Results
Reports fiscal 2026 Q3 net sales decline of 8%, with organic sales growth of 2%
Delivers fiscal 2026 Q3 GAAP diluted EPS of $1.45 versus $1.52 in the prior year, and
non-GAAP EPS of $1.54 versus $1.56
Raises fiscal 2026 outlook for non-GAAP diluted EPS from $2.70 or better to $2.85 or
better
WALNUT CREEK, Calif.--(BUSINESS WIRE)-- Central Garden & Pet Company (NASDAQ:
CENT) (NASDAQ: CENTA) (“Central”), a leading consumer goods company in the pet and
garden industries, today announced financial results for its fiscal 2026 third quarter ended
June 27, 2026.
This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20260805868011/en/
"Third quarter results
showed continued
strength across the
business with
improvements in both organic sales and margins versus last year, reflecting sharp execution
and favorable margins due primarily to the exit of the pet distribution business earlier this
year. Following the quarter, we entered into a definitive agreement to acquire a majority
interest in TRIXIE, the leading European pet supplies and pet snacks company, a significant
step in expanding our presence in Europe," said Niko Lahanas, CEO of Central Garden &
Pet. "As we enter the final phase of the garden season, and given the strength we've seen
across the business, we're raising our fiscal year outlook."
Central Garden & Pet raises fiscal 2026 outlook for non-GAAP diluted EPS
from $2.70 or better to $2.85 or better
Fiscal 2026 Third Quarter Financial Results
(All comparisons versus Q3 FY 2025)
Net sales were $882 million compared with $961 million, a decrease of 8%. Organic net
sales, which take into account the exit of the pet distribution business at the beginning of the
quarter, were $862 million compared with $842 million, an increase of 2%.
Gross profit was $317 million, compared with $332 million, a decrease of 5%, with gross
margin expanding by 130 basis points to 35.9% from 34.6%.
SG&A was $191 million, compared with $197 million, a decrease of 3%. Non-GAAP SG&A
was $182 million, compared with $193 million, a decrease of 6%.
Operating income totaled $126 million, compared with $135 million, a decrease of 7%, with
operating margin expanding by 20 basis points to 14.3% from 14.1%. On a non-GAAP basis,
operating income totaled $136 million, compared with $139 million, a decrease of only 2%,
with operating margin expanding by 90 basis points to 15.4% from 14.5%.
Other income was $2 million, slightly above the prior year.
Net interest expense was $8 million, lower than a year ago.
Net income was $90 million, compared with $95 million, a decrease of 5%, or $1.45 per
diluted share compared with $1.52, a decrease of $0.07. On a non-GAAP basis, net income
was $96 million, compared with $98 million, a decrease of 2%, or $1.54 per diluted share
compared with $1.56, a decrease of $0.02.
Adjusted EBITDA was $162 million, compared with $167 million, a decrease of $5 million,
with margin expanding by 100 basis points to 18.3% from 17.3%.
Pet Segment Third Quarter Fiscal 2026 Results
(All comparisons versus Q3 FY 2025)
Net sales in the Pet segment were $400 million, compared with $493 million, a decrease of
19% reflecting the exit of the pet distribution business. Organic net sales in the Pet segment
were $380 million, an increase of 2%.
Operating income was $67 million, compared with $76 million, a decrease of 12%, with
margin of 16.7% versus 15.5%, up 120 basis points. Non-GAAP operating income was $76
million, compared with $78 million, a decrease of 2%, with margin of 19.0% versus 15.8%,
up 320 basis points.
Adjusted EBITDA was $86 million, compared with $88 million, a decrease of $2 million, with
margin of 21.4% versus 17.9%, up 350 basis points.
Garden Segment Third Quarter Fiscal 2026 Results
(All comparisons versus Q3 FY 2025)
Net sales in the Garden segment were $482 million, compared with $468 million, an
increase of 3%. The increase was primarily driven by Wild Bird, Fertilizer and Controls, and
Grass Seeds.
Operating income was $90 million, compared with $83 million, an increase of 9%, with
margin expanding by 100 basis points to 18.7% from 17.7%. Non-GAAP operating income
was $91 million, compared with $85 million, an increase of 7%, with margin of 18.9% versus
18.2%, up 70 basis points.
Adjusted EBITDA was $101 million, compared with $96 million, an increase of $5 million,
with margin of 20.9% versus 20.4%, up 50 basis points.
Liquidity and Debt
(All comparisons versus Q3 FY 2025)
Cash provided by operations was $327 million, compared with $265 million, primarily
reflecting seasonal changes in working capital.
Cash and cash equivalents at June 27, 2026, totaled $997 million, compared with $713
million.
Total debt was $1.2 billion, consistent with the prior year period, with strong liquidity
supporting continued investment capacity and financial flexibility.
Gross leverage, calculated using the definitions for Indebtedness and EBITDA in Central's
credit agreement, ended the third quarter at 2.8x, compared with 2.9x in the prior year and
below the target range of 3.0 to 3.5x. Net leverage was 0.5x.
As of June 27, 2026, $128 million remained available for future stock repurchases.
Acquisition of TRIXIE
Following the close of the quarter, Central entered into a definitive agreement to acquire an
80% interest in TRIXIE Heimtierbedarf GmbH & Co. KG (“TRIXIE”), the leading European
pet supplies and pet snacks company, for €340 million in cash at closing plus up to €60
million in additional earn-out payments, for total consideration of up to €400 million.
Together, Central and TRIXIE will create the leading global player in pet supplies.
TRIXIE serves over 30,000 pet retail stores internationally with a broad portfolio of pet
products, approximately 90% of which are own-brand. The transaction will give Central a
differentiated presence with approximately 10% of net sales generated outside of the United
States and establish a scaled platform to consolidate the fragmented European pet specialty
market. Members of TRIXIE's leadership team will retain a minority stake and continue in key
roles. The transaction is expected to close in the first half of fiscal 2027.
Fiscal 2026 Guidance
Reflecting year-to-date results and improved visibility into the balance of the year, Central
raises its outlook for fiscal 2026 non-GAAP diluted EPS from $2.70 or better to $2.85 or
better, driven by continued margin discipline, ongoing investment in growth initiatives, and
portfolio optimization.
The outlook incorporates current assumptions regarding a competitive and promotional retail
environment, a value-oriented consumer, existing tariffs, and inflation in select commodities.
It also assumes continued stability across key commodities despite a dynamic
macroeconomic and geopolitical backdrop.
Capital expenditures for fiscal 2026 are projected to be approximately $50 million, focused
on maintenance, productivity initiatives, and targeted growth investments across both
segments.
This outlook excludes any potential impacts from further acquisitions, divestitures, or
restructuring activities that may occur during the remainder of fiscal 2026, including projects
under Central's Cost and Simplicity agenda, as well as further tariff refunds.
Conference Call
Central will hold a conference call today at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time),
hosted by CEO Niko Lahanas and CFO Brad Smith, to discuss these results and to provide
a general business update. The conference call and related materials can be accessed at
http://ir.central.com.
Alternatively, to listen to the call by telephone, dial (201) 689-8345 (domestic and
international) using confirmation #13760653.
About Central Garden & Pet
Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA) is a leading
consumer goods company in the pet and garden industries. Guided by the belief that home
is central to life, the company's purpose is to proudly nurture happy and healthy homes. For
over 45 years, its innovative and trusted solutions have helped lawns grow greener, gardens
bloom bigger, pets live healthier, and communities grow stronger. Central is home to a
diversified portfolio of market-leading brands including Amdro® , Aqueon® , Best Bully
Sticks® , Cadet® , C&S® , Farnam® , Ferry-Morse® , Kaytee® , Nylabone® , Pennington® , Sevin®
and Zoёcon® . With fiscal 2025 net sales of $3.1 billion, the company has strong
manufacturing and logistics capabilities supported by a passionate, entrepreneurial growth
culture that incorporates sustainability. Central is headquartered in Walnut Creek, California,
and employs more than 6,000 people, primarily across North America. Visit
www.central.com to learn more.
Safe Harbor Statement
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: The
statements contained in this release which are not historical facts, including statements
concerning evolving consumer demand and unfavorable retailer dynamics, productivity
initiatives, estimated capital spending, earnings guidance for fiscal 2026, the expected timing
of the closing of the acquisition of TRIXIE, and our ability to successfully manage and grow
TRIXIE’s business, are forward-looking statements that are subject to risks and uncertainties
that could cause actual results to differ materially from those set forth in or implied by
forward-looking statements. All forward-looking statements are based upon Central's current
expectations and various assumptions. There are a number of risks and uncertainties that
could cause actual results to differ materially from the forward-looking statements contained
in this release including, but not limited to, the following factors:
economic uncertainty and other adverse macroeconomic conditions, including a
potential recession or inflationary pressure;
impacts of further tariffs or a trade war and our ability to receive tariff refunds;
risks associated with international sourcing;
the failure to obtain certain required regulatory approvals or the failure to satisfy any of
the other closing conditions to the completion of the TRIXIE transaction;
our ability to close the TRIXIE acquisition in a timely basis or at all;
our ability to integrate the acquired company and realize the potential benefits of the
TRIXIE transaction to Central and our customers;
fluctuations in energy prices, fuel and related petrochemical costs;
the impact of the new pet distribution partnership on our financial results and ability to
distribute and promote our pet branded products;
declines in consumer spending and the associated increased inventory risk;
seasonality and fluctuations in our operating results and cash flow;
adverse weather conditions and climate change;
the success of our Central to Home strategy and our Cost and Simplicity agenda;
fluctuations in market prices for seeds and grains and other raw materials, including
the impact of significant declines in grass seed market prices on our inventory
valuation;
risks associated with new product introductions, including the risk that our new
products will not produce sufficient sales to recoup our investment;
dependence on a small number of customers for a significant portion of our business;
consolidation trends in the retail industry;
supply shortages in pet birds, small animals and fish;
potential credit risk associated with certain brick and mortar retailers in the pet
specialty segment;
reductions in demand for our product categories;
competition in our industries;
continuing implementation of an enterprise resource planning information technology
system;
regulatory issues;
potential environmental liabilities;
access to and cost of additional capital;
the impact of product recalls;
risks associated with our acquisition strategy, including our ability to successfully
integrate acquisitions and the impact of purchase accounting on our financial results;
potential goodwill or intangible asset impairment;
the potential for significant deficiencies or material weaknesses in internal control over
financial reporting, particularly of acquired companies;
our dependence upon our key executives;
our ability to recruit and retain members of our management team and employees to
support our businesses;
potential costs and risks associated with actual or potential cyberattacks;
our ability to protect our trademarks and other proprietary rights;
litigation and product liability claims;
the impact of new accounting regulations and the possibility our effective tax rate will
increase as a result of future changes in the corporate tax rate or other tax law
changes;
potential dilution from issuance of authorized shares; and
the voting power associated with our Class B stock.
These and other risks are described in greater detail in Central’s Annual Report on Form 10K for the fiscal year ended September 27, 2025, filed with the Securities and Exchange
Commission on November 26, 2025. Central has not filed its Form 10-Q for the fiscal quarter
ended June 27, 2026. As a result, all financial results described here should be considered
preliminary, and are subject to change to reflect any necessary adjustments or changes in
accounting estimates that are identified prior to the time the Company files the Form 10-Q.
Central assumes no obligation to publicly update these forward-looking statements to reflect
new information, future events, or any other development.
CENTRAL GARDEN & PET COMPANY
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts, unaudited)
June 28,
2025
June 27, 2026
ASSETS
Current assets:
Cash and cash equivalents
$
Restricted cash
Accounts receivable (less allowance for credit losses of $8,884, $8,585 and $8,011)
Inventories, net
Prepaid expenses and other
Total current assets
Plant, property and equipment, net
Goodwill
Other intangible assets, net
Operating lease right-of-use assets
$
713,049
14,690
522,712
718,267
31,497
$
882,488
15,945
325,297
722,106
30,294
2,134,699
349,324
545,841
426,901
189,559
143,629
2,000,215
366,362
554,692
455,100
220,182
60,771
1,976,130
363,188
554,692
447,643
222,863
61,127
$ 3,789,953
$ 3,657,322
$ 3,625,643
$
$
$
Other assets
Total
996,710
15,504
460,243
631,649
30,593
September
27, 2025
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable
Accrued expenses
Current lease liabilities
Current portion of long-term debt
Total current liabilities
Long-term debt
Long-term lease liabilities
Deferred income taxes and other long-term obligations
Equity:
Common stock ($0.01 par value; 9,650,221 shares outstanding at June 27, 2026,
June 28, 2025 and September 27, 2025)
Class A common stock ($0.01 par value: 51,290,706, 51,556,941 and 51,618,682
shares outstanding at June 27, 2026, June 28, 2025 and September 27, 2025,
respectively)
Class B stock ($0.01 par value: 1,602,374 shares outstanding at June 27, 2026,
June 28, 2025 and September 27, 2025)
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Total Central Garden & Pet Company shareholders’ equity
Noncontrolling interest
Total equity
Total
217,277
295,689
50,686
55
210,926
294,395
56,779
81
234,618
247,213
56,865
62
563,707
1,193,003
164,849
121,493
562,181
1,191,179
188,307
125,125
538,758
1,191,641
191,739
118,572
97
97
97
513
516
516
16
573,770
1,175,716
(4,442)
16
566,236
1,024,902
(3,532)
16
571,392
1,015,096
(3,849)
1,745,670
1,231
1,588,235
2,295
1,583,268
1,665
1,746,901
1,590,530
1,584,933
$ 3,789,953
$ 3,657,322
$ 3,625,643
CENTRAL GARDEN & PET COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts, unaudited)
Three Months Ended
Net sales
Cost of goods sold
Gross profit
Nine Months Ended
June 27,
June 28,
June 27, 2026 June 28, 2025
2026
2025
$
882,362 $
960,913 $ 2,405,887 $ 2,450,886
565,444
628,903
1,598,797
1,650,094
Selling, general and administrative expenses
Operating income
Interest expense
Interest income
Other income
Income before income taxes and noncontrolling interest
Income tax expense
Income including noncontrolling interest
Net income attributable to noncontrolling interest
Net income attributable to Central Garden & Pet Company
Net income per share attributable to Central Garden & Pet Company:
Basic
Diluted
Weighted average shares used in the computation of net income per
share:
Basic
Diluted
316,918
191,074
332,010
196,884
807,090
550,777
800,792
544,350
125,844
(14,279)
6,512
1,511
135,126
(14,360)
5,517
1,069
256,313
(42,858)
18,240
1,342
256,442
(43,340)
17,409
96
119,588
29,596
127,352
31,941
233,037
56,214
230,607
56,208
89,992
136
95,411
404
176,823
705
174,399
1,750
$
89,856
$
95,007
$
176,118
$
172,649
$
1.46
$
1.53
$
2.87
$
2.72
$
1.45
$
1.52
$
2.84
$
2.69
61,452
61,947
61,980
62,610
61,409
61,925
63,557
64,283
CENTRAL GARDEN & PET COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
Nine Months Ended
June 28,
June 27, 2026
2025
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization
Amortization of deferred financing costs
Non-cash lease expense
Stock-based compensation
Gain on divestiture
Deferred income taxes
Other operating activities
Changes in assets and liabilities (excluding businesses acquired):
Accounts receivable
Inventories
Prepaid expenses and other assets
Accounts payable
Accrued expenses
Other long-term obligations
Operating lease liabilities
$
176,823
$
174,399
60,977
1,879
43,725
15,699
(2,479)
4,481
1,898
64,063
2,021
45,118
15,572
—
4,587
(1,851)
(130,770)
22,268
2,522
8,189
47,630
(1,548)
(43,699)
(195,704)
39,800
(3,992)
(1,471)
48,390
2,831
(43,983)
Net cash provided by operating activities
Cash flows from investing activities:
Additions to property, plant and equipment
Payments to acquire companies, net of cash acquired
Proceeds from divestiture
Other investing activities
207,595
149,780
(33,851)
(57,720)
30,644
(50)
(30,580)
(3,318)
—
(150)
Net cash used in investing activities
Cash flows from financing activities:
Repayments of long-term debt
Repurchase of common stock, including shares surrendered for tax withholding
Distribution to noncontrolling interest
Payment of financing costs
(60,977)
(34,048)
(53)
(28,822)
(1,139)
(2,329)
(202)
(154,734)
(1,346)
—
Net cash used in financing activities
Effect of exchange rate changes on cash and equivalents
(32,343)
(494)
(156,282)
(114)
Net increase/(decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
113,781
898,433
(40,664)
768,403
Cash, cash equivalents and restricted cash at end of period
$ 1,012,214
$
727,739
Supplemental information:
Cash paid for interest
$
48,291
$
48,778
Cash paid for income taxes – net of refunds
$
35,295
$
44,281
Lease liabilities arising from obtaining right-of-use assets
$
9,519
$
56,833
Use of Non-GAAP Financial Measures
We report our financial results in accordance with GAAP. However, to supplement the
financial results prepared in accordance with GAAP, we use non-GAAP financial measures
including non-GAAP net income and diluted net income per share, non-GAAP operating
income, organic net sales and adjusted EBITDA. Management uses these non-GAAP
financial measures that exclude the impact of specific items (described below) in making
financial, operating and planning decisions and in evaluating our performance. Also,
management believes that these non-GAAP financial measures may be useful to investors in
their assessment of our ongoing operating performance and provide additional meaningful
comparisons between current results and results in prior operating periods. While
management believes that non-GAAP measures are useful supplemental information, such
adjusted results are not intended to replace our GAAP financial results and should be read
in conjunction with those GAAP results.
We have also provided organic net sales, a non-GAAP measure that excludes the impact of
businesses purchased or exited in the prior 12 months, because we believe it permits
investors to better understand the performance of our historical business without the impact
of recent acquisitions or dispositions.
Adjusted EBITDA is defined by us as income before income tax, net other expense, net
interest expense and depreciation and amortization and stock-based compensation expense
(or operating income plus depreciation and amortization expense and stock-based
compensation expense). Adjusted EBITDA further excludes charges related to facility
closures. We present adjusted EBITDA because we believe that adjusted EBITDA is a useful
supplemental measure in evaluating the cash flows and performance of our business and
provides greater transparency into our results of operations. Adjusted EBITDA is used by
our management to perform such evaluations. Adjusted EBITDA should not be considered
in isolation or as a substitute for cash flow from operations, income from operations or other
income statement measures prepared in accordance with GAAP. We believe that adjusted
EBITDA is frequently used by investors, securities analysts and other interested parties in
their evaluation of companies, many of which present adjusted EBITDA when reporting their
results. Other companies may calculate adjusted EBITDA differently and it may not be
comparable.
The reconciliations of these non-GAAP measures to the most directly comparable financial
measures calculated and presented in accordance with GAAP are shown in the tables
below.
Non-GAAP financial measures reflect adjustments based on the following items:
Facility closures and business exit: we have excluded charges related to the closure of
distribution and manufacturing facilities and our decisions to exit businesses as they
represent infrequent transactions that impact the comparability between operating
periods.
Tariff refunds: we have excluded the impact of tariff refunds received for certain tariffs
previously imposed under the International Emergency Economic Powers Act which
were deemed unconstitutional. We believe the tariff refund amounts we have received
represent infrequent transactions that impact the comparability between operating
periods.
Business contribution to new pet distribution partnership formation:we have excluded
the gain related to the divestiture of the pet distribution business and its contribution to
the formation of a partnership as it represents an infrequent transaction that impacts
the comparability between operating periods.
From time to time in the future, there may be other items that we may exclude if we believe
that doing so is consistent with the goal of providing useful supplemental information to
investors and management.
We have not provided a reconciliation of non-GAAP measures to the corresponding GAAP
measures on a forward-looking basis as we cannot do so without unreasonable efforts due to
the potential variability and limited visibility of excluded items; these excluded items may
include facility closures and exit costs, impairment charges and restructuring costs, among
others.
- During the third quarter of fiscal 2026, we recognized incremental expense of $13.8
million in the consolidated statement of operations, of which $13.0 million in our Pet
segment related to the exit of a minor business and the closure of two facilities, and
$0.8 million in our Garden segment related to the closure of three distribution centers
in fiscal 2025 and 2024.
- During the third quarter of fiscal 2026, we recognized incremental income in our Pet
segment of $3.6 million for tariff refunds received.
- During the third quarter of fiscal 2026, we recognized incremental income of $2.5
million in Other Income from the contribution of our pet distribution business to the
formation of a new new partnership.
- During the first six months of fiscal 2026, we recognized incremental expense of $8.0
million in the condensed consolidated statement of operations, of which $7.3 million in
our Garden segment related to the closure of three distribution centers in fiscal 2025
and 2024 and $0.7 million in our Pet segment related to the closure of a sales and
logistics facility in Pennsylvania.
- During the third quarter of fiscal 2025, we recognized incremental expense of $3.9
million in the consolidated statement of operations, $2.2 million in our Garden segment
related to closing a distribution facility in Ontario, California and beginning the
consolidation of our Western distribution network and an incremental $1.7 million in our
Pet segment related to the decision to winddown our operations in the U.K.
- During the second quarter of fiscal 2025, we recognized incremental expense of $5.3
million in the condensed consolidated statement of operations, related to the decision
to wind-down our operations in the U.K. and the related facility there as we move to a
direct-export model.
Net Income and Diluted Net Income Per Share
GAAP to Non-GAAP Reconciliation
GAAP net income attributable to Central Garden
& Pet Company
Facility closures
Tariff refunds
Pet distribution business divestiture
Tax effect of adjustments
Non-GAAP net income attributable to Central
Garden & Pet Company
GAAP diluted net income per share
Non-GAAP diluted net income per share
Shares used in GAAP and non-GAAP diluted net
earnings per share calculation
Three Months Ended
Nine Months Ended
June 27,
June 28,
June 27, 2026 June 28, 2025
2026
2025
(in thousands, except per share amounts)
$
89,856
13,757
(3,606)
(2,479)
(1,900)
$
95,007 $
3,915
—
—
(1,003)
176,118 $
21,729
(3,606)
(2,479)
(3,770)
172,649
9,254
—
—
(2,258)
$
95,628
$
97,919
$
187,992
$
179,645
$
$
1.45
1.54
$
$
1.52
1.56
$
$
2.84
3.04
$
$
2.69
2.79
(1) (4) (5) (6)
(2)
(3)
61,947
62,610
61,925
64,283
Operating Income
GAAP to Non-GAAP
Reconciliation
Net sales
$
Cost of goods sold
Gross profit
Selling, general and
administrative expenses
Income from operations
$
316,918
$
191,074
$
(1) (2) (4)
Gross margin
Operating margin
Operating Income
GAAP to Non-GAAP
Reconciliation
Net sales
$
Cost of goods sold
Gross profit
Selling, general and
administrative expenses
Income from operations
Three Months Ended June 27, 2026
Nine Months Ended June 27, 2026
Non-GAAP
Non-GAAP
GAAP
adjustments Non-GAAP
GAAP
adjustments Non-GAAP
(in thousands)
882,362 $
1,354 $
883,716 $ 2,405,887 $
1,354 $ 2,407,241
565,444
129
565,573
1,598,797
646
1,599,443
$
125,844
$
Gross margin
Operating margin
$
318,143
(8,926)
182,148
10,151 $
135,995
18,123 $
274,436
11.4%
Three Months Ended June 28, 2025
Nine Months Ended June 28, 2025
Non-GAAP
Non-GAAP
GAAP
adjustments Non-GAAP
GAAP
adjustments Non-GAAP
(in thousands)
960,913 $
— $
960,913 $ 2,450,886 $
— $ 2,450,886
628,903
(248)
628,655
1,650,094
(4,661)
1,645,433
332,010
$
248 $
135,126
$
332,258
(3,667)
193,217
3,915 $
139,041
$
800,792
$
544,350
$
256,442
$
4,661 $
805,453
(4,593)
539,757
9,254 $
265,696
34.6%
34.6%
32.7%
32.9%
14.1%
14.5%
10.5%
10.8%
Three Months Ended
Nine Months Ended
June 27, 2026 June 28, 2025 June 27, 2026 June 28, 2025
(in thousands)
$
66,818 $
76,199 $
194,440 $
188,070
12,963
1,671
13,696
7,010
(3,606)
—
(3,606)
—
$
Non-GAAP operating margin
Non-GAAP operating margin
$
533,362
10.7%
GAAP operating margin
GAAP operating margin
256,313
(17,415)
15.4%
(2)
Non-GAAP operating income
$
807,798
14.3%
Tariff refunds received
Facility closures
550,777
708 $
33.6%
(1) (4) (5) (6)
GAAP operating income
$
33.5%
GAAP operating income
Facility closures
Garden Segment Operating Income
GAAP to Non-GAAP Reconciliation
807,090
36.0%
Pet Segment Operating Income
GAAP to Non-GAAP Reconciliation
Non-GAAP operating income
$
35.9%
196,884
(5) (6)
1,225 $
76,175
$
77,870
$
204,530
$
195,080
16.7%
15.5%
15.0%
13.7%
19.0%
15.8%
15.8%
14.2%
Three Months Ended
Nine Months Ended
June 27, 2026 June 28, 2025 June 27, 2026 June 28, 2025
(in thousands)
$
90,051 $
82,989 $
146,340 $
144,143
794
2,244
8,033
2,244
(1) (4) (5)
$
90,845
$
85,233
$
154,373
$
146,387
18.7%
17.7%
13.2%
13.4%
18.9%
18.2%
13.9%
13.6%
Organic Net Sales
GAAP to Non-GAAP
Reconciliation
Q3 FY 26
Q3 FY 25
$ increase (decrease)
% increase (decrease)
Organic Pet Segment Net Sales
GAAP to Non-GAAP
Reconciliation
Q3 FY 26
Q3 FY 25
$ increase (decrease)
% increase (decrease)
Three Months Ended June 27, 2026
Nine Months Ended June 27, 2026
Effect of
Effect of
acquisitions
acquisitions
&
&
Net sales
divestitures
Net sales
Net sales
divestitures
Net sales
(GAAP)
on net sales
organic
(GAAP)
on net sales
organic
(in millions)
$
882.4
$
20.2 $
862.2 $
2,405.9
$
237.2 $
2,168.7
960.9
842.2
2,450.9
2,099.2
118.7
351.7
$
(78.5)
$
20.0
(8.2)%
2.4%
$
(92.0)
$
6.5
(18.7)%
$
(1.8)%
Net income attributable to Central Garden & Pet Company
Interest expense, net
Other income
Income tax expense
$
Net income attributable to noncontrolling interest
Income (loss) from operations
Depreciation & amortization
Noncash stock-based compensation
Facility closures and tariff refunds received
$
1.7%
Pet
(1) (2)
$
Adjusted EBITDA
69.5
3.3%
$
Net income attributable to noncontrolling interest
Income (loss) from operations
Depreciation & amortization
Noncash stock-based compensation
(5)
$
$
(5.9)%
33.9
3.3%
Three Months Ended June 27, 2026
Garden
Corporate
Total
(in thousands)
— $
— $
— $
89,856
—
—
—
7,767
—
—
—
(1,511)
—
—
—
29,596
136
—
—
—
90,051
9,987
—
794
(31,025) $
229
6,245
—
125,844
19,634
6,245
10,151
85,593 $
100,832 $
(24,551) $
161,874
Pet
Net income attributable to Central Garden & Pet Company
Interest expense, net
Other income
Income tax expense
(80.6)
66,818
9,418
—
9,357
Adjusted EBITDA
GAAP to Non-GAAP Reconciliation
Adjusted EBITDA
(45.0)
Three Months Ended June 27, 2026
Nine Months Ended June 27, 2026
Effect of
Effect of
acquisitions
acquisitions
&
&
Net sales
divestitures Net sales
Net sales
divestitures Net sales
(GAAP)
on net sales organic
(GAAP)
on net sales organic
(in millions)
$
400.5
$
20.2 $
380.3 $
1,293.1
$
237.2 $
1,055.9
492.5
373.8
1,373.7
1,022.0
118.7
351.7
Adjusted EBITDA
GAAP to Non-GAAP Reconciliation
Facility closures & business exit
$
Three Months Ended June 28, 2025
Garden
Corporate
Total
(in thousands)
— $
— $
— $
95,007
—
—
—
8,843
—
—
—
(1,069)
—
—
—
31,941
404
—
—
—
76,199
10,391
—
1,671
82,989
10,383
—
2,244
(24,062) $
709
6,044
—
135,126
21,483
6,044
3,915
88,261 $
95,616 $
(17,309) $
166,568
Adjusted EBITDA
GAAP to Non-GAAP Reconciliation
Pet
Net income attributable to Central Garden & Pet Company
Interest expense, net
Other income
Income tax expense
$
Net income attributable to noncontrolling interest
Income (loss) from operations
Depreciation & amortization
Noncash stock-based compensation
Facility closures and tariff refunds received
(1) (2) (4)
$
Adjusted EBITDA
194,440
30,017
—
10,090
146,340
30,252
—
8,033
(84,467) $
708
15,699
—
256,313
60,977
15,699
18,123
234,547 $
184,625 $
(68,060) $
351,112
Adjusted EBITDA
GAAP to Non-GAAP Reconciliation
Pet
Net income attributable to Central Garden & Pet Company
Interest expense, net
Other income
Income tax expense
$
Net income attributable to noncontrolling interest
Income (loss) from operations
Depreciation & amortization
Noncash stock-based compensation
Facility closures and business exit
(5) (6)
Adjusted EBITDA
$
Nine Months Ended June 27, 2026
Garden
Corporate
Total
(in thousands)
— $
— $
— $
176,118
—
—
—
24,618
—
—
—
(1,342)
—
—
—
56,214
705
—
—
—
Nine Months Ended June 28, 2025
Garden
Corporate
Total
(in thousands)
— $
— $
— $
172,649
—
—
—
25,931
—
—
—
(96)
—
—
—
56,208
1,750
—
—
—
188,070
29,969
—
7,010
144,144
31,957
—
2,244
(75,772) $
2,137
15,572
—
256,442
64,063
15,572
9,254
225,049 $
178,345 $
(58,063) $
345,331
View source version on businesswire.com:
https://www.businesswire.com/news/home/20260805868011/en/
Investor & Media Contact
Friederike Edelmann
VP, Investor Relations & Corporate Sustainability
(925) 412-6726
[email protected]
Source: Central Garden & Pet Company